infectious diseases
Market Access/ News/ News/ News/ R&D
Basilea preps key US filing for MRSA antibiotic ceftobiprole
Phil Taylor
antibiotic, Basilea, ceftobiprole, infectious diseases, MRSA, Zevtera
0 Comment
Market Access/ News/ News/ News/ Patients
GSK pledges £1bn drive for infectious disease R&D
Phil Taylor
developing countries, GlaxoSmithKline, HIV, infectious diseases, Malaria, Novartis, patients, tropical diseases, tuberculosis
0 Comment
2nd Annual mRNA-Based Therapeutics Summit
Serena Pickford Phimmai
Biotech, coronavirus, COVID-19, infectious diseases, vaccine
0 Comment
Accelerating platforms for mRNA vaccines
Readout sets up phase 3 for Valneva/Pfizer’s Lyme disease jab
Phil Taylor
infectious diseases, Lyme disease, Pfizer, vaccine, Valneva
0 Comment
Market Access/ News/ News/ News/ R&D
Cidara and Mundipharma prep filings for antifungal rezafungin
Phil Taylor
antifungal, Cidara Therapeutics, infectious diseases, Mundipharma, rezafungin
0 Comment
The Protein Degradation & Targeting Undruggables Congress
Sarah Rowlands
Biotech, clinical trials, infectious diseases, Oncology, pharma
0 Comment
Protein Degradation Event
3rd Inflammasome Therapeutics Summit
jenna.warren@hansonwade.com
drug discovery, immuno-oncology, infectious diseases, inflammasome, innate immunity
0 Comment
Targeting the Inflammasome
Partner content/ Patients/ Press releases
Taking a de-centralized approach to cure the Hepatitis C epidemic
Fishawack Marketing
dermatology, Hepatitis, infectious diseases, patient centricity, patients
0 Comment
We compare approaches to combatting Hepatitis C